National Organization for Rare Disorders, Inc.
It is possible that the main title of the report General Myoclonus is not the name you expected.
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
Myoclonus is the term used to describe the sudden, involuntary jerking of a muscle or group of muscles caused by muscle contractions (positive myoclonus) or muscle relaxation (negative myoclonus). The twitching or jerking of muscles cannot be controlled by the person experiencing it. Myoclonic jerks may occur infrequently or many times a minute. They sometimes occur in response to an external event or when a person attempts to make a movement. By itself, myoclonus may be seen as a symptom rather than a disease. To some degree, it may occur occasionally to otherwise healthy people. (For instance, hiccups may be considered a type of myoclonus.) In severe cases, it can interfere with movement control and balance, and limit various everyday activities such as eating or talking.
There are different forms of myoclonus and they are classified in different ways. One way of classifying the different forms is by their cause. Some of the types of myoclonus are:
This occurs in neurologically normal people. The occurrence of myoclonus during sleep and sleep transitions is the most common example.
In this type, the myoclonic jerks or twitches are usually the most prominent or only clinical finding. This type of myoclonus usually progresses slowly or not at all. There are hereditary (autosomal dominant) and non-inherited, random (sporadic) forms.
Progressive myoclonus epilepsy (PME)
This is a group of diseases characterized by myoclonus, epilepsy, and other symptoms such as trouble walking or speaking. These disorders tend to get worse over time (progressive).
This typically occurs just at the moment of dropping off to sleep. In some cases, the affected individual does not find it particularly troublesome. In other cases, it may interfere with the sleep process. Myoclonus may be a symptom in certain sleep disorders such as restless legs syndrome.
Symptomatic (secondary) myoclonus
This is the most common category and usually is found in the setting of an identifiable underlying disorder. Myoclonus may not be the most prominent clinical symptom. Common co-existing problems include ataxia, dementia, and Parkinsonism. Myoclonus may also be a symptom associated with infections, non-neurologic medical illnesses, toxic-metabolic states, and storage diseases.
Myoclonus is caused by an abrupt and brief discharge of motor neurons to affected muscles. In most cases, this results from a disturbance in the central nervous system, although it is believed that in rare cases may be caused by an injury to the nerves outside the central nervous system (peripheral nerves). Several different locations within the brain are thought to be involved in myoclonus. As a result, various types of testing is usually required to define the cause of myoclonus.
The locations that cause myoclonus are reflected in the physiological classification of myoclonus:
- Cortical (Focal or multifocal source)
- Cortical-Subcortical (e.g. Myoclonic Epilepsy)
Chemicals that carry messages from one nerve cell to another (neurotransmitters) may play a role. In some cases, myoclonus may be present because of an imbalance in these chemicals. However, the specific causes are not well understood at this time.
Myoclonus affects males and females in equal numbers. Some forms of myoclonus are common and some forms are rare. In general, the incidence of myoclonus is 1.3 cases per 100,000 person-years, and the prevalence is 8.6 cases per 100,000 populations.
Symptoms of the following disorders can be similar to those of myoclonus. Comparisons may be useful for a differential diagnosis:
Tourette syndrome is a neurologic movement disorder that is characterized by repetitive motor and vocal tics. The first symptoms are usually rapid eye blinking or facial grimaces. Symptoms may also include facial tics and involuntary movements of the extremities, shoulders, and the voluntary muscles. Inarticulate sounds or sometimes inappropriate words may occur. Tourette syndrome is not a progressive or degenerative disorder; rather, symptoms tend to be variable and follow a chronic waxing and waning course. Symptoms usually begin before the age of 16 years. (For more information on this disorder, choose "Tourette" as your search term in the Rare Disease Database.)
Jumping Frenchmen of Maine is a very rare disorder characterized by an extreme startle response. The symptoms occur as a response to sudden, unexpected noise or movement. The extreme startle reaction includes jumping, raising the arms, hitting, yelling, unintelligible speech, and/or imitation or repetition of another person's body movements (echopraxia). The intensity of the response increases with fatigue and stress. (For more information on this disorder, choose "Jumping Frenchmen of Maine" as your search term in the Rare Disease Database.)
Huntington's disease (Huntington's chorea) is a rare inherited, progressively degenerative neurological disorder characterized by involuntary muscle movements and dementia. Initially there are personality changes and uncontrolled rapid jerky muscle movements. In time, speech and memory become impaired and involuntary muscle movements become more frequent and severe. As Huntington's disease progresses, there is a further loss of cognitive abilities and dementia. The symptoms of this disorder usually begin during adulthood, generally after the age of forty. (For more information on this disorder choose, "Huntington's" as your search term in the Rare Disease Database.)
Torsion dystonia is a rare inherited neurological disorder characterized by involuntary contortions of the muscles in the neck, torso, arms, and legs. Occasionally only one or a few muscles are involved. People with torsion dystonia typically have an awkward, sideways gait. Other symptoms may include foot drag, cramps on the hands and feet, difficulty in grasping objects, and unclear speech. The involuntary movements of dystonia are slow writhing movements. (For more information on this disorder, choose "Torsion Dystonia" as your search term in the Rare Disease Database.)
Benign essential tremor is a rare neurological disorder characterized by a rhythmical tremor that may be pronounced. This disorder typically affects the upper extremities. The tremors may be aggravated by stress, anxiety, fatigue, and/or cold temperatures. Relief from the tremors may be achieved by rest and sedation. The symptoms of benign essential tremor generally stabilize after a period of progression. (For more information on this disorder, choose "Benign Essential Tremor" as your search term in the Rare Disease Database.)
If the cause for the underlying disorder cannot be cured, then the standard treatment for myoclonus is medications that may help reduce symptoms. The first line of therapy depends on where the myoclonus originates within the nervous system (i.e. physiological classification).. This would include levetiracetam and clonazepam, a type of tranquilizer, and other drugs known as benzodiazepine derivatives. The beneficial effects of certain drugs, including clonazepam, may diminish over time.
Many of the drugs used for myoclonus, such as barbiturates, phenytoin, and primidone, are also used to treat epilepsy. Certain of these drugs may have side effects such as sleepiness, unsteady gait (ataxia), or lethargy, and patients and their families should be aware of these beforehand.
Genetic counseling will be of benefit for patients with the inherited forms of myoclonus and their families.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the National Institutes of Health (NIH) in Bethesda, MD, contact the NIH Patient Recruitment Office:
Toll-free: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Some studies have shown that doses of 5-hydroxytryptophan (5-HTP), a building block of serotonin, leads to improvement in patients with some types of myoclonus. However, other studies indicate that this therapy is not effective in all people with myoclonus and may even cause the jerks and twitches to worsen in some affected individuals.
Because myoclonus is complex in nature it may require a combination of drugs for effective treatment. Some drugs currently being studied in different combinations include levetiracetam, clonazepam, sodium valproate, and primidone. In some people, treatment may also include hormonal therapy.
Caviness J. Myoclonus in NORD Guide to Rare Disorders. Lippincott, Williams & Wilkins. 2003. 627-28.
Camfield P, Camfield C. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study. Epilepsia. 2007; April 18 (epub ahead of print).
Abraham A, Elena C, Melamed E, Djaldetti R. Successful treatment of truncal myoclonus. Mov Disord. 2007; 5;22(7):1055-6.
Walters AS. Clinical identification of the simple sleep-related movement disorders. Chest. 2007; 131:1260-66.
Caviness JN, Brown P. Myoclonus: Current Concepts and Recent Advances. Lancet Neurology 2004;3:598-607.
National Institute of Neurological Disorders and Stroke Myoclonus Fact Sheet. January 4, 2012. http://www.ninds.nih.gov/disorders/myoclonus/detail_myoclonus.htm?css=print Accessed on:January 13, 2012.
National Sleep Foundation
1010 N. Glebe Road
Arlington, VA 22201
8301 Professional Place
Landover, MD 20785-7223
Opsoclonus-Myoclonus Support Network, Inc.
2116 Casa Linda Dr.
West Covina, CA 91791
Email: sandragreenberg@ hotmail.com
NIH/National Institute of Neurological Disorders and Stroke
P.O. Box 5801
Bethesda, MD 20824
National Pediatric Myoclonus Center
P.O. Box 19643
Springfield, IL 62794-9643
2900 John St., Suite 402
Ontario, L3R 5G3
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
PO Box 241956
Los Angeles, CA 90024
Movement Disorder Society
555 E. Wells Street
Milwaukee, WI 53202-3823
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email email@example.com
Last Updated: 1/20/2012
Copyright 1986, 1987, 1988, 1990, 1991, 1992, 1993, 1996, 1999, 2007, 2009, 2012 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.